Bellmunt Risk Score as a Prognostic Tool in Metastatic Castration-Resistant Prostate Cancer Survival

In this prognostic study of patients with mCRPC, the BRS was validated as a prognostic tool that provides clinically meaningful information across different treatment lines. Due to its simplicity, the BRS is a practical aid for guiding treatment decisions and facilitating prognostic discussions in routine clinical care.